Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
VALSARTAN HYDROCHLOROTHIAZIDE
Imbat Limited
VALSARTAN HYDROCHLOROTHIAZIDE
160/25 mg/mg
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE USER CO-DIOVAN ® 160MG/25MG FILM-COATED TABLETS (valsartan / hydrochlorothiazide) Your medicine is available using the name Co-Diovan 160mg/25mg film-coated tablets, but will be referred to as Co- Diovan throughout the leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What CO-DIOVAN is and what it is used for 2. Before you take Co-Diovan 3. How to take Co-Diovan 4. Possible side effects 5. How to store Co-Diovan 6. Further information 1. WHAT CO-DIOVAN IS AND WHAT IT IS USED FOR Co-Diovan film-coated tablets contain two active substances called valsartan and hydrochlorothiazide. Both of these substances help to control high blood pressure (hypertension). VALSARTAN belongs to a class of medicines known as “angiotensin II receptor antagonists”, which help to control high blood pressure. Angiotensin II is a substance in the body that causes vessels to tighten, thus causing your blood pressure to increase. Valsartan works by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered. HYDROCHLOROTHIAZIDE belongs to a group of medicines called thiazide diuretics (also known as “water tablets”). Hydrochlorothiazide increas Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Co-Diovan 160mg/25mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 160mg of valsartan and 25mg OF hydrochlorothiazide. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from UK:_ Brown orange, ovaloid tablet imprinted with "HXH" on one side and "NVR" on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension in adults. Co-Diovan fixed-dose combination is indicated in patients whose blood pressure is not adequately controlled on valsartan or hydrochlorothiazide monotherapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ The recommended dose of Co-Diovan 160 mg/25 mg is one film-coated tablet once daily. Dose titration with the individual components is recommended. In each case, up-titration of individual components to the next dose should be followed in order to reduce the risk of hypotension and other adverse events. When clinically appropriate direct change from monotherapy to the fixed combination may be considered in patients whose blood pressure is not adequately controlled on valsartan or hydrochlorothiazide monotherapy, provided the recommended dose titration sequence for the individual components is followed. The clinical response to Co-Diovan should be evaluated after initiating therapy and if blood pressure remains uncontrolled, the dose may be increased by increasing either one of the components to a maximum dose of Co-Diovan 320 mg/25 mg. The antihypertensive effect is substantially present within 2 weeks. In most patients, maximal effects are observed within 4 weeks. However, in some patients 4-8 weeks treatment may be required. This should be taken into accou Read the complete document